Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-188875
Filing Date
2021-06-11
Accepted
2021-06-11 16:15:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 65510
  Complete submission text file 0001193125-21-188875.txt   66430
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)